J Sport Rehabil. 2021 Feb 16;30(5):804-811. doi: 10.1123/jsr.2020-0176.
Localized and widespread hyperalgesia has been observed in patients with patellofemoral pain. Diacutaneous fibrolysis (DF) has shown to be effective in reducing pain in several musculoskeletal conditions including patellofemoral pain syndrome, but no studies have evaluated the effects of this technique in reducing localized and widespread hyperalgesia.
To assess the effect of DF on the pressure pain threshold and muscle length tests in patients with patellofemoral pain syndrome.
A single-group, pretest-posttest clinical trial.
University of Zaragoza.
Forty-six subjects with patellofemoral pain (20 males and 26 females: age 27.8 [6.9] y).
Three sessions of DF.
Pressure pain threshold using a handheld pressure algometer (4 sites around the knee, on tibialis anterior muscle, and one remote site on the upper contralateral limb); muscle length test of the iliotibial band, rectus femoris, and hamstring muscles; and patient-perceived treatment effect score.
The application of 3 sessions of DF significantly increased the pressure pain threshold in all sites at posttreatment evaluation (P < .001) and at a 1-week follow-up (P < .001). A significant increase in muscle length was also observed at the posttreatment evaluation (P < .001) and 1-week follow-up (P < .001). Ninety-seven percent of the patients reported subjective improvement at posttreatment and at 1-week follow-up.
This study found that local and widespread hyperalgesia was significantly reduced after 3 sessions of diacutaneous fibrolysis and at the 1-week follow-up. A significant improvement on muscle length tests was also observed, with high clinical satisfaction among patients.
髌股疼痛综合征患者存在局部和广泛的痛觉过敏。皮内切开纤维松解术(DF)已被证明在多种肌肉骨骼疾病中有效,包括髌股疼痛综合征,可以减轻疼痛,但尚无研究评估该技术在减轻局部和广泛痛觉过敏方面的效果。
评估皮内切开纤维松解术对髌股疼痛综合征患者的压痛阈和肌肉长度测试的影响。
单组、前后测临床试验。
萨拉戈萨大学。
46 名髌股疼痛患者(20 名男性和 26 名女性;年龄 27.8[6.9]岁)。
DF 治疗 3 次。
使用手持压力测痛仪(膝关节周围 4 个部位、胫骨前肌和对侧上肢 1 个远处部位)测量压痛阈;评估髂胫束、股直肌和腘绳肌的肌肉长度测试;以及患者感知的治疗效果评分。
DF 治疗 3 次后,所有治疗部位的压痛阈在治疗后评估(P <.001)和 1 周随访时(P <.001)均显著增加。治疗后评估和 1 周随访时肌肉长度也显著增加(P <.001)。97%的患者在治疗后和 1 周随访时报告主观改善。
本研究发现,皮内切开纤维松解术 3 次治疗后和 1 周随访时,局部和广泛的痛觉过敏显著减轻。肌肉长度测试也显著改善,患者的临床满意度高。